Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Adult Glioblastoma Multiforme: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Adult Glioblastoma Multiforme: 1 US clinical trial tracked, none currently recruiting.

Adult Glioblastoma Multiforme is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, running 1 of these trials.

Enrollment posture brief

Registry condition adult-glioblastoma-multiforme

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Adult Glioblastoma Multi (this)Adult Glioblastoma Multi (th…0%
Open-enrollment share among volume-matched conditions near Adult Glioblastoma Multiforme

Adult Glioblastoma Multiforme has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adult Glioblastoma Multiforme on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adult Glioblastoma Multiforme is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Adult Glioblastoma Multiforme records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

olaratumab Biological
1 trials
ramucirumab Biological
1 trials

US sites by state

Facility locations filed on Adult Glioblastoma Multiforme trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Pennsylvania 1 trials
Ohio 1 trials
North Carolina 1 trials
Michigan 1 trials
Maryland 1 trials
Massachusetts 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Adult Glioblastoma Multiforme page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adult Glioblastoma Multiforme condition card totals 1 registered trials; most-linked intervention olaratumab; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.